JAZZ vs SCI
Jazz Pharmaceuticals PLC (JAZZ) versus Service Corporation International (SCI) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Service Corporation International (SCI) is a personal services company listed on NYSE.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SCI revenue for 2025-12-31 was $4.31B. Net income was $542.6M. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. SCI currently screens at market cap $10.01B and trailing P/E 19.1.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SCI currently screens at market cap $10.01B and trailing P/E 19.1.
Not investment advice. Open the JAZZ and SCI stock pages for the full models.
Not investment advice.